SHANG.FOS.PHARM.GR.H YC 1 (08HH) — Defensive Interval Ratio
SHANG.FOS.PHARM.GR.H YC 1 (08HH) has a Defensive Interval Ratio of 117 days as of March 2026. Defensive assets of €11.69 Billion (cash €-, short-term investments €2.23 Billion, receivables €9.47 Billion) cover 117 days of daily cash needs of €100.22 Million/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
SHANG.FOS.PHARM.GR.H YC 1 Defensive Interval Ratio (2021–2025)
This chart shows how SHANG.FOS.PHARM.GR.H YC 1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 117 days, meaning defensive assets of €11.69 Billion can fund 117 days of operations without new revenue. For the complete balance sheet picture, see SHANG.FOS.PHARM.GR.H YC 1 balance sheet assets.
Annual Defensive Interval Ratio for SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for SHANG.FOS.PHARM.GR.H YC 1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See SHANG.FOS.PHARM.GR.H YC 1 current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 116 days | €11.62 Billion | €99.79 Million/day | €- | €2.25 Billion | ▲ +14 days |
| 2024 | 103 days | €10.55 Billion | €102.61 Million/day | €- | €2.60 Billion | ▼ 0 days |
| 2023 | 103 days | €9.53 Billion | €92.49 Million/day | €- | €1.89 Billion | ▲ +10 days |
| 2022 | 93 days | €8.52 Billion | €91.23 Million/day | €- | €928.53 Million | ▼ -35 days |
| 2021 | 128 days | €10.27 Billion | €80.32 Million/day | €- | €4.24 Billion | — |